Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 6, 2023; 11(10): 2254-2259
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2254
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2254
Time | Incidents |
8 yr ago | The patient’s mother was diagnosed gestational diabetes (controlled with diet) during her first gestation, and deliver a girl with a birth weight of 4000 g, who presented severe hypoglycemia with brain damage after birth |
At the mother’s 25th wk of gestation | The mother was diagnosed with pregestational diabetes mellitus and was treated by insulin |
20 min after birth | The patient was diagnosed mild asphyxia, with an APGAR score of 7/10/10, and was brought to the neonatal intensive care unit |
2 h after birth | The infant presented intractable hypoglycemia and hyperinsulinism |
During hospitalization | He was initially treated with glucose and hydrocortisone infusion. Next, he was treated with octreotide and glucagon. whole-exome sequencing was performed because the upper treatments are ineffective. Thus, he was treated with diazoxide, which was effective |
25 d after birth | The patient was discharged from the hospital and continued to take diazoxide orally, and the medication was tapered off |
30 d after birth | The whole-exome sequencing identified a missense heterozygous mutation in the ABCC8 |
Now | The patient’s blood glucose level is average, and his growth and development are acceptable. His mother’s fasting glucose level is impaired |
- Citation: Liu MT, Yang HX. Neonatal hyperinsulinism with an ABCC8 mutation: A case report. World J Clin Cases 2023; 11(10): 2254-2259
- URL: https://www.wjgnet.com/2307-8960/full/v11/i10/2254.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i10.2254